ERBB2 and triple-negative breast carcinoma: These differences may relate to differences in intrinsic subtypes of breast cancer studied, as it is well known that hormone-receptor-(ER, PR)-positive, HER2-positive, and triple-negative breast cancers show major differences in metabolic demands [17, 18].